Implementation of TERT promoter mutations improve prognostication of the WHO classification in meningioma

Christian Mirian; Kathrine Grell; Tareq A Juratli; Felix Sahm; Sabine Spiegl-Kreinecker; Matthieu Peyre; Annamaria Biczok; Joerg Christian Tonn; Stéphane Goutagny; Luca Bertero; Andrea Daniela Maier; Lasse Rehné Jensen; Gabriele Schackert; Helle Broholm; David Scheie; Daniel P Cahill; Priscilla K Brastianos; Jane Skjøth-Rasmussen; Kåre Fugleholm; Morten Ziebell; Tina Nørgaard Munch; Bjarne Winther Kristensen; Tiit Mathiesen

doi:10.1111/nan.12773

Implementation of TERT promoter mutations improve prognostication of the WHO classification in meningioma

Christian Mirian, Kathrine Grell, Tareq A Juratli, Felix Sahm, Sabine Spiegl-Kreinecker, Matthieu Peyre, Annamaria Biczok, Joerg Christian Tonn, Stéphane Goutagny, Luca Bertero, Andrea Daniela Maier, Lasse Rehné Jensen, Gabriele Schackert, Helle Broholm, David Scheie, Daniel P Cahill, Priscilla K Brastianos, Jane Skjøth-Rasmussen, Kåre Fugleholm, Morten ZiebellTina Nørgaard Munch, Bjarne Winther Kristensen, Tiit Mathiesen

Research output: Contribution to journal › Journal article › Research › peer-review

8 Citations (Scopus)

40 Downloads (Pure)

Abstract

TERT promoter mutations have been associated with increased risk of recurrence in meningioma cohorts, thus a potential biomarker for aggressive phenotypes. A main purpose of refining tumour classification is better predictions on the patient level. We compiled data from previous published cohorts to investigate patient-level predictions of recurrence based on TERTp-mut status. Implementation of TERTp-mut into the WHO grading led to better patient prognostication by improved prediction of recurrence. Our results support implementation of TERTp-mut into diagnostics and classification of meningiomas

Original language	English
Article number	e12773
Journal	Neuropathology and Applied Neurobiology
Volume	48
Issue number	3
Number of pages	5
ISSN	0305-1846
DOIs	https://doi.org/10.1111/nan.12773
Publication status	Published - 2022

Access to Document

10.1111/nan.12773

FulltextAccepted author manuscript, 568 KB

Cite this

Mirian, C., Grell, K., Juratli, T. A., Sahm, F., Spiegl-Kreinecker, S., Peyre, M., Biczok, A., Tonn, J. C., Goutagny, S., Bertero, L., Maier, A. D., Jensen, L. R., Schackert, G., Broholm, H., Scheie, D., Cahill, D. P., Brastianos, P. K., Skjøth-Rasmussen, J., Fugleholm, K., ... Mathiesen, T. (2022). Implementation of TERT promoter mutations improve prognostication of the WHO classification in meningioma. Neuropathology and Applied Neurobiology, 48(3), [e12773]. https://doi.org/10.1111/nan.12773

Implementation of TERT promoter mutations improve prognostication of the WHO classification in meningioma. / Mirian, Christian; Grell, Kathrine; Juratli, Tareq A; Sahm, Felix; Spiegl-Kreinecker, Sabine; Peyre, Matthieu; Biczok, Annamaria; Tonn, Joerg Christian; Goutagny, Stéphane; Bertero, Luca; Maier, Andrea Daniela; Jensen, Lasse Rehné; Schackert, Gabriele; Broholm, Helle; Scheie, David; Cahill, Daniel P; Brastianos, Priscilla K; Skjøth-Rasmussen, Jane ; Fugleholm, Kåre; Ziebell, Morten; Munch, Tina Nørgaard ; Kristensen, Bjarne Winther ; Mathiesen, Tiit.

In: Neuropathology and Applied Neurobiology, Vol. 48, No. 3, e12773, 2022.

Research output: Contribution to journal › Journal article › Research › peer-review

Mirian, C, Grell, K, Juratli, TA, Sahm, F, Spiegl-Kreinecker, S, Peyre, M, Biczok, A, Tonn, JC, Goutagny, S, Bertero, L, Maier, AD, Jensen, LR, Schackert, G, Broholm, H, Scheie, D, Cahill, DP, Brastianos, PK, Skjøth-Rasmussen, J , Fugleholm, K, Ziebell, M, Munch, TN , Kristensen, BW & Mathiesen, T 2022, 'Implementation of TERT promoter mutations improve prognostication of the WHO classification in meningioma', Neuropathology and Applied Neurobiology, vol. 48, no. 3, e12773. https://doi.org/10.1111/nan.12773

Mirian, Christian ; Grell, Kathrine ; Juratli, Tareq A ; Sahm, Felix ; Spiegl-Kreinecker, Sabine ; Peyre, Matthieu ; Biczok, Annamaria ; Tonn, Joerg Christian ; Goutagny, Stéphane ; Bertero, Luca ; Maier, Andrea Daniela ; Jensen, Lasse Rehné ; Schackert, Gabriele ; Broholm, Helle ; Scheie, David ; Cahill, Daniel P ; Brastianos, Priscilla K ; Skjøth-Rasmussen, Jane ; Fugleholm, Kåre ; Ziebell, Morten ; Munch, Tina Nørgaard ; Kristensen, Bjarne Winther ; Mathiesen, Tiit. / Implementation of TERT promoter mutations improve prognostication of the WHO classification in meningioma. In: Neuropathology and Applied Neurobiology. 2022 ; Vol. 48, No. 3.

@article{38c195035c6b47f6903a5533e5923e33,

title = "Implementation of TERT promoter mutations improve prognostication of the WHO classification in meningioma",

abstract = "TERT promoter mutations have been associated with increased risk of recurrence in meningioma cohorts, thus a potential biomarker for aggressive phenotypes. A main purpose of refining tumour classification is better predictions on the patient level. We compiled data from previous published cohorts to investigate patient-level predictions of recurrence based on TERTp-mut status. Implementation of TERTp-mut into the WHO grading led to better patient prognostication by improved prediction of recurrence. Our results support implementation of TERTp-mut into diagnostics and classification of meningiomas",

author = "Christian Mirian and Kathrine Grell and Juratli, {Tareq A} and Felix Sahm and Sabine Spiegl-Kreinecker and Matthieu Peyre and Annamaria Biczok and Tonn, {Joerg Christian} and St{\'e}phane Goutagny and Luca Bertero and Maier, {Andrea Daniela} and Jensen, {Lasse Rehn{\'e}} and Gabriele Schackert and Helle Broholm and David Scheie and Cahill, {Daniel P} and Brastianos, {Priscilla K} and Jane Skj{\o}th-Rasmussen and K{\aa}re Fugleholm and Morten Ziebell and Munch, {Tina N{\o}rgaard} and Kristensen, {Bjarne Winther} and Tiit Mathiesen",

year = "2022",

doi = "10.1111/nan.12773",

language = "English",

volume = "48",

journal = "Neuropathology and Applied Neurobiology",

issn = "0305-1846",

publisher = "Wiley-Blackwell",

number = "3",

}

TY - JOUR

T1 - Implementation of TERT promoter mutations improve prognostication of the WHO classification in meningioma

AU - Mirian, Christian

AU - Grell, Kathrine

AU - Juratli, Tareq A

AU - Sahm, Felix

AU - Spiegl-Kreinecker, Sabine

AU - Peyre, Matthieu

AU - Biczok, Annamaria

AU - Tonn, Joerg Christian

AU - Goutagny, Stéphane

AU - Bertero, Luca

AU - Maier, Andrea Daniela

AU - Jensen, Lasse Rehné

AU - Schackert, Gabriele

AU - Broholm, Helle

AU - Scheie, David

AU - Cahill, Daniel P

AU - Brastianos, Priscilla K

AU - Skjøth-Rasmussen, Jane

AU - Fugleholm, Kåre

AU - Ziebell, Morten

AU - Munch, Tina Nørgaard

AU - Kristensen, Bjarne Winther

AU - Mathiesen, Tiit

PY - 2022

Y1 - 2022

N2 - TERT promoter mutations have been associated with increased risk of recurrence in meningioma cohorts, thus a potential biomarker for aggressive phenotypes. A main purpose of refining tumour classification is better predictions on the patient level. We compiled data from previous published cohorts to investigate patient-level predictions of recurrence based on TERTp-mut status. Implementation of TERTp-mut into the WHO grading led to better patient prognostication by improved prediction of recurrence. Our results support implementation of TERTp-mut into diagnostics and classification of meningiomas

AB - TERT promoter mutations have been associated with increased risk of recurrence in meningioma cohorts, thus a potential biomarker for aggressive phenotypes. A main purpose of refining tumour classification is better predictions on the patient level. We compiled data from previous published cohorts to investigate patient-level predictions of recurrence based on TERTp-mut status. Implementation of TERTp-mut into the WHO grading led to better patient prognostication by improved prediction of recurrence. Our results support implementation of TERTp-mut into diagnostics and classification of meningiomas

U2 - 10.1111/nan.12773

DO - 10.1111/nan.12773

M3 - Journal article

C2 - 34799864

VL - 48

JO - Neuropathology and Applied Neurobiology

JF - Neuropathology and Applied Neurobiology

SN - 0305-1846

IS - 3

M1 - e12773

ER -